HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Linda T Vahdat Selected Research

Epothilones (Epothilone)

10/2010Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
4/2008Epothilones: clinical update and future directions.
4/2008Clinical studies with epothilones for the treatment of metastatic breast cancer.
8/2007Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Linda T Vahdat Research Topics

Disease

34Breast Neoplasms (Breast Cancer)
11/2015 - 01/2007
19Neoplasms (Cancer)
09/2015 - 01/2006
7Neutropenia
09/2015 - 04/2008
6Peripheral Nervous System Diseases (PNS Diseases)
07/2013 - 09/2004
5Neoplasm Metastasis (Metastasis)
11/2015 - 03/2012
3Fatigue
11/2011 - 06/2010
3Disease Progression
05/2011 - 08/2007
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2013 - 01/2007
2Lung Neoplasms (Lung Cancer)
01/2008 - 01/2007
1Pruritus (Itching)
05/2015
1Alopecia (Baldness)
05/2015
1Exanthema (Rash)
05/2015
1Inflammation
05/2015
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Leukopenia
10/2013
1Carcinoma (Carcinomatosis)
10/2013
1Sarcoma (Soft Tissue Sarcoma)
04/2013
1Asthenia
03/2011
1Ovarian Neoplasms (Ovarian Cancer)
10/2010
1Pain (Aches)
04/2010
1Kidney Neoplasms (Kidney Cancer)
01/2007
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2007
1Erythema
07/2004

Drug/Important Bio-Agent (IBA)

9taxaneIBA
07/2014 - 08/2007
8ixabepilone (BMS 247550)FDA Link
09/2014 - 08/2007
82- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
07/2014 - 06/2009
7Mesylates (Mesylate)IBA
07/2014 - 06/2009
5capecitabine (Xeloda)FDA Link
10/2013 - 11/2007
5TaxoidsIBA
11/2011 - 11/2007
4epothilone B (EPO906)IBA
11/2012 - 08/2007
4AnthracyclinesIBA
11/2011 - 11/2007
4Epothilones (Epothilone)IBA
10/2010 - 08/2007
3Estrogens (Estrogen)FDA Link
05/2015 - 01/2013
3sagopiloneIBA
10/2010 - 04/2008
2Glycoproteins (Glycoprotein)IBA
05/2015 - 02/2012
2glembatumumab vedotinIBA
05/2015 - 02/2012
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
07/2014 - 01/2013
2Paclitaxel (Taxol)FDA LinkGeneric
10/2013 - 04/2008
2TubulinIBA
07/2013 - 08/2007
2Versicans (Versican)IBA
10/2012 - 03/2012
2desoxyepothilone B (epothilone D)IBA
04/2008 - 04/2008
1MicroRNAs (MicroRNA)IBA
11/2015
1irinotecan (Camptosar)FDA LinkGeneric
09/2015
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
09/2015
1Aromatase (CYP19)IBA
05/2015
1trastuzumab (Herceptin)FDA Link
01/2015
1cyanine dye 5IBA
09/2014
1tumor-associated antigen GA733IBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1ChromatinIBA
01/2014
1TransferasesIBA
10/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2013
1Filgrastim (Neupogen)FDA Link
10/2013
1tipifarnib (R115777)IBA
10/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013
1Formaldehyde (Formol)FDA Link
06/2013
1ParaffinIBA
06/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2013
1dasatinib (BMS 354825)FDA Link
04/2013
1HormonesIBA
04/2013
1Phosphotransferases (Kinase)IBA
04/2013
1CalciumIBA
01/2013
1Progesterone Receptors (Progesterone Receptor)IBA
01/2013
1Proteoglycans (Proteoglycan)IBA
10/2012
1Biological Markers (Surrogate Marker)IBA
03/2011
1PlatinumIBA
10/2010
1halichondrin BIBA
06/2009

Therapy/Procedure

12Drug Therapy (Chemotherapy)
11/2015 - 09/2004
1Adjuvant Chemotherapy
07/2014
1Biological Therapy
05/2011
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2008
1Individualized Medicine
01/2007
1Activities of Daily Living (ADL)
07/2004